Arrayit has announced that the High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland has purchased Arrayit's Nanoprint microarray platform.
The technology is being used to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis and lupus.
Arrayit's Nanoprint microarray platform deposits nanolitre quantities of proteins onto glass substrates to create the chips.
Johns Hopkins is also considering Arrayit's consumable stream of substrates and reagents.
'Because of the high capacity of the Nanoprint, we use it to print 17,000 human proteins on a single glass slide,' said Dr Heng Zhu, assistant professor at Johns Hopkins.
'You can see all 17,000 proteins for their auto-immunity, covering 80 per cent of the human proteome; we call that The Human Proteome Chip.' Arrayit Nanoprint platforms have been installed at other major research and diagnostics centres, including Harvard University in Massachusetts, Sandia National Laboratories in New Mexico, Scripps Research Institute in Florida, The Biodesign Institute in Arizona and Mount Sinai School of Medicine in New York City.
